Atrial fibrillation (AF) is the most common sustained arrhythmia of the Western world. The
increased ischemic stroke risk of the AF patient is one of the most important clinical issues to …

Patients with atrial fibrillation (AF) have an increased stroke risk compared with those in
sinus rhythm, although the absolute risk for individual patients is modulated by the presence …

Atrial fibrillation (AF) is a major and widely recognized risk factor for cardioembolic stroke.
Prophylactic therapy for the prevention of stroke in patients with AF is often achieved through …

Oral anticoagulant therapy is the mainstay of stroke prevention in patients with atrial
fibrillation; it is highly effective at reducing stroke risk, but its use can be limited by increased …

The risk of ischemic stroke is increased 5-fold in patients with atrial fibrillation (AF). 1 While
this risk has been recognized for more than 20 years, several therapeutic options available …

Importance of the field: Atrial fibrillation (AF) is the most common cardiac arrhythmia
encountered in clinical practice and is associated with an increased risk of stroke, mortality …

BACKGROUND: Atrial fibrillation is associated with substantial mortality and morbidity from
stroke and thromboembolism. Despite an efficacious oral anticoagulation therapy (warfarin) …

Non-valvular atrial fibrillation (AF) is the most common cardiac arrhythmia in the clinical
setting. AF increases both the risk and severity of strokes, and is associated with substantial …

Atrial fibrillation (AF) is associated with a 5-fold greater risk of ischemic stroke or systemic
embolism compared with normal sinus rhythm. Cardioembolic AF-related strokes are often …

Background and Purpose—Although the stroke rate associated with atrial fibrillation has
declined over the last 10 years, the emerging atrial fibrillation epidemic threatens to increase …